The natural killer T (NKT) cell ligand ␣ -galactosylceramide ( ␣ -GalCer) exhibits profound antitumor activities in vivo that resemble interleukin (IL)-12-mediated antitumor activities. Because of these similarities between the activities of ␣ -GalCer and IL-12, we investigated the involvement of IL-12 in the activation of NKT cells by ␣ -GalCer. We first established, using purified subsets of various lymphocyte populations, that ␣ -GalCer selectively activates NKT cells for production of interferon (IFN)-␥ . Production of IFN-␥ by NKT cells in response to ␣ -GalCer required IL-12 produced by dendritic cells (DCs) and direct contact between NKT cells and DCs through CD40/CD40 ligand interactions. Moreover, ␣ -GalCer strongly induced the expression of IL-12 receptor on NKT cells from wild-type but not CD1 Ϫ / Ϫ or V ␣ 14 Ϫ / Ϫ mice. This effect of ␣ -GalCer required the production of IFN-␥ by NKT cells and production of IL-12 by DCs. Finally, we showed that treatment of mice with suboptimal doses of ␣ -GalCer together with suboptimal doses of IL-12 resulted in strongly enhanced natural killing activity and IFN-␥ production. Collectively, these findings indicate an important role for DC-produced IL-12 in the activation of NKT cells by ␣ -GalCer and suggest that NKT cells may be able to condition DCs for subsequent immune responses. Our results also suggest a novel approach for immunotherapy of cancer. The in vivo antitumor activity of ␣ -GalCer strongly resembles the antitumor activity mediated by the cytokine 9) . Moreover, both ␣ -GalCer and IL-12 are 1 Abbreviations used in this paper: ␣ -GalCer, ␣ -galactosylceramide; DC, dendritic cell; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; NKT, natural killer T; RT, reverse transcription.
. It was demonstrated recently that NKT cells are strongly stimulated by the glycolipid ␣ -galactosylceramide ( ␣ -GalCer), a potent inducer of antitumor immunity in mice (3) (4) (5) . Recognition of ␣ -GalCer by NKT cells appeared to depend on the interaction of the invariant TCR of these cells with ␣ -GalCer presented by the nonclassical MHC molecule CD1d on APCs (6) . Stimulation of NKT cells by ␣ -GalCer resulted in the production of large amounts of IFN-␥ and some IL-4, and the development of a cytotoxic phenotype (7) .
The in vivo antitumor activity of ␣ -GalCer strongly resembles the antitumor activity mediated by the cytokine IL-12 (8, 9) . Moreover, both ␣ -GalCer and IL-12 are
Immunopotentiating Mechanisms of NKT Cell Ligand ␣ -GalCer strong inducers of NKT cell activity and exert their antitumor activities through activation of these cells (8, 9) . Because of these striking similarities between ␣ -GalCer and IL-12 for activation of NKT cells, we decided to investigate whether ␣ -GalCer activation of NKT cells involves regulation by . First, we demonstrated that NKT cells are the main, if not the only, target for activation by ␣ -GalCer in spleen cell populations of mice. Second, we showed that endogenous IL-12 produced by dendritic cells (DCs) is critically important for the activation of NKT cells by ␣ -GalCer and that the interaction between DCs and NKT cells involves CD40 and its ligand. Third, ␣ -GalCer induced the expression of IL-12R on NKT cells, which required the production of IFN-␥ by NKT cells. Fourth, ␣ -GalCer acted synergistically with IL-12 in the activation of natural killing activity and IFN-␥ production in vivo. Collectively, these findings indicate that ␣ -GalCer exerts its function through IL-12 and suggest a novel approach for therapeutic intervention in cancer and other disease processes.
Materials and Methods
Mice. C57BL/6 mice were purchased from Charles River Japan. V ␣ 14 NKT cell-deficient (J ␣ 281 Ϫ / Ϫ ) and CD1d Ϫ / Ϫ mice were established by specific deletion of the J ␣ 281 and CD1d gene segment, respectively (3, 10) . All mice used in this study were at 5-8 wk of age and were maintained in specific pathogenfree conditions.
-octadecanetriol] used for this study was provided by Dr. Y. Koezuka (Kirin Brewery Co., Ltd., Gunma, Japan [4, 5] ). The stock solution of ␣ -GalCer (220 g/ml) was diluted in 0.5% polysorbate 20 (Nikko Chemical) in 0.9% NaCl solution. This stock solution was further diluted into an appropriate concentration with saline and used for the experiments. A vehicle control solution was prepared from a solution of 0.5% polysorbate 20 in 0.9% NaCl solution. The vehicle control was used in all experiments.
Isolation of Lymphoid Cell Subsets by FACS ® . Spleen cells were incubated on nylon wool columns for 45 min, and the nonadherent cells were used for the isolation of NKT cells, NK cells, CD4 ϩ T cells, and CD8 ϩ T cells by cell sorting using a FACS Vantage™ instrument (Becton Dickinson). All mAbs used in these experiments (mAbs against NK1.1, CD4, CD8, and TCR-␣ / ␤ ) were purchased from PharMingen. Unless noted otherwise, NK1.1 ϩ TCR-␣ / ␤ ϩ cells were used as purified NKT cells. The stained cells were isolated using the FACS Vantage™. The purity of the sorted cells was Ͼ 98%. The details of the staining and sorting have been described previously (11) .
Coculture of DCs and NKT Cells. DCs were prepared according to the method of Steinman et al. (12) with some modifications. In brief, spleen cells were incubated in 10-cm plastic dishes (Falcon; Becton Dickinson) for 2 h, and the nonadherent cells were removed from the culture. The adherent cells were further incubated overnight and the nonadherent cells were harvested. Then, CD11c ϩ B220 Ϫ CD4 Ϫ CD8 Ϫ cells were isolated from the nonadherent populations by cell sorting and used as the source of DCs. Generally, DCs (10 5 ) were cocultured with purified NK1.1 ϩ TCR-␣ / ␤ ϩ NKT cells (2 ϫ 10 5 ) in the presence of 50 ng/ml of ␣ -GalCer in 96-well U-bottomed plates (Costar Corp.). After incubation for 36 h, the culture supernatants were harvested to detect cytokine levels.
Detection of Cytokine Activity. IL-4 or IFN-␥ activity in culture supernatants was determined using the Biotrac™ mouse IL-4 or Biotrac™ mouse IFN-␥ ELISA system (Nycomed Amersham plc). Serum samples were obtained from C57BL/6 mice 24 h after injection of ␣ -GalCer (200 ng/mouse) and/or IL-12 (200 U/mouse; donated by Genetics Institute, Inc., Cambridge, MA), and cytokine levels were measured using ELISA kits (Nycomed Amersham plc). IL-12 p70 activity in culture supernatants was measured using Intertest-12X™ ELISA kits (Genzyme Corp.).
Cytotoxicity Assay. The natural killing activity of spleen cells was determined by 4-h 51 Cr-release assays using YAC-1 cells as target. 1 lytic unit (LU) was defined as the number of effector cells required to cause 25% lysis of 2,500 target cells as described previously (13) . Quantitative Reverse Transcription PCR Assay for IL-12R mRNA Measurement. C57BL/6, CD1d Ϫ/Ϫ , and V␣14 NKT cell-deficient mice were injected with ␣-GalCer (2 g/mouse i.v.) or vehicle. At different time points (0-6 h) after treatment, mice were killed and spleen cells were isolated. TaqMan™ real-time quantitative reverse transcription (RT)-PCR assay was carried out for the detection of IL-12R mRNA expression by these cells according to published methods (14) . In brief, total RNA extracts from the cells were added to the master mixture. To detect the amount of the IL-12R mRNA RT-PCR amplificon, target (IL-12R␤1, IL-12R␤2) and control (glyceraldehyde 3-phosphate dehydrogenase [GAPDH]) hybridization probes were mixed with target and control PCR primers, respectively. This mixture was transferred to a set of thermocycler tubes and transcribed at 42ЊC for 30 min, followed by 40 cycles of amplification at 95ЊC for 15 s and 60ЊC for 1.5 min, and analyzed using an ABI PRISM 7700 sequence detector (Applied Biosystems). IL-12R␤1 and IL-12R␤2 mRNA expression were estimated from the ratio of fluorescence intensity to GAPDH. IL-12R expression induced by ␣-GalCer is indicated in the figures as induction index, calculated as follows: induction index ϭ IL-12R expression of ␣-GalCer-stimulated sample/IL-12R expression of unstimulated sample.
TaqMan™ probes used for these analyses are as follows:
PCR primers used for these analyses are as follows: IL-12␤1 mRNA, forward primer (-563F) 5Ј-AATGTGTCTGAAGAGGC-CGGT-3Ј and reverse primer (-657R) 5Ј-GAGTTAACCTGAG-GTCCGCAGT-3Ј; IL-12R␤2 mRNA, forward primer (-529F) 5Ј-ATCTCAGTTGGTGTTGCTCCA-3Ј and reverse primer (-602R) 5Ј-GCCACAGTTCCATTTTCTCCT-3Ј; GAPDH, forward primer (-368F) 5Ј-CTTCACCACCATGGAGAAGGC-3Ј and reverse primer (-605R) 5Ј-GGCATGGACTGTGGTCAT-GAG-3Ј.
Blocking of IL-12R Induction by Anti-IFN-␥ mAb.
Wild-type C57BL/6 mice were injected with 500 g i.p. anti-IFN-␥ mAb (R4-6A2; PharMingen) or IL-12 (C15.1 and C15.6, donated by Dr. G. Trinchieri, Wistar Institute of Anatomy and Biology, Philadelphia, PA) at 0 and 1 d before priming with ␣-GalCer. As a control, the same amount of rat IgG1 (PharMingen) was injected intraperitoneally into control mice before injection of ␣-GalCer.
Results
␣-GalCer Selectively Activates NK1.1 ϩ TCR-␣/␤ ϩ NKT Cells. To provide direct evidence that NKT cells are the only target cells for activation by ␣-GalCer, various lymphoid subsets were isolated from mouse spleen cell suspensions by flow cytometry and cocultured with DCs in the presence of ␣-GalCer. After 36 h of culture, the supernatants were harvested and their IL-4 and IFN-␥ contents were measured by ELISA. Fig. 1 shows that purified NK1.1 ϩ T cells produce higher levels of IL-4 and IFN-␥ than unfractionated spleen cells. The IFN-␥ produced in these cultures was not derived from classical NK cells, because enrichment of NK1.1 ϩ TCR-␣/␤ Ϫ NK cells showed no significant cytokine production. In contrast, NK1.1 ϩ TCR-␣/␤ ϩ cells, which represent the NKT cell population, revealed markedly high levels of IL-4 and IFN-␥ production. Although CD4 ϩ T cells produced higher levels of cytokines compared with unfractionated spleen cells, this appeared to be due to the presence of CD4 ϩ NK1.1 ϩ NKT cells, because CD4 ϩ NK1.1 Ϫ cells produced neither IL-4 nor IFN-␥ in response to ␣-GalCer. Culture of NK1.1 ϩ TCR-␣/␤ ϩ NKT cells alone or with DCs in the absence of ␣-GalCer caused no significant production of IFN-␥ or IL-4, indicating that DCs are essential for the stimulation of cytokine production by NKT cells.
Endogenous IL-12 Production by DCs Is Essential for the
Triggering of NKT Cells. Fig. 2 A shows that coculture of DCs and NKT cells in the presence of ␣-GalCer results in high levels of IFN-␥ production. However, addition of anti-IL-12 mAb into these cultures caused a marked inhibition of IFN-␥ production. Such inhibition was not observed when control anti-CD8 rat IgG mAb was added. Therefore, these results indicated that endogenously produced IL-12 by DCs was essential for the early activation of NKT cells by ␣-GalCer. The effect of mAbs against CD40 and CD40L on the activation of NKT cells by ␣-GalCer was also investigated (Fig. 2 B) . Both anti-CD40 mAb and anti-CD40L mAb greatly inhibited the production of IFN-␥ by NKT cells in response to ␣-GalCer. These findings suggested that direct contact between DCs and NKT cells through CD40/CD40L interactions is critically important for the activation of NKT cells by ␣-GalCer. To study the requirements for IL-12 production by DCs in these cultures in further detail, IL-12 p70 activity in culture supernatants was measured by ELISA. As shown in Fig. 2 C, DCs produced IL-12 p70 when cultured with NKT cells and ␣-GalCer. However, DCs did not produce IL-12 p70 when cultured with ␣-GalCer alone or when cultured with ␣-GalCer and NK (NK1.1 ϩ TCR-␣/␤ Ϫ ) cells.
␣-GalCer Induces IL-12R Expression on NKT Cells. The effect of ␣-GalCer on the induction of IL-12R mRNA expression in spleen cells was examined by RT-PCR. As shown in Fig. 3 , intravenous injection of ␣-GalCer into C57BL/6 mice caused the induction of mRNA for both IL-12R␤1 and IL-12R␤2 in spleen cells within 4 h. This upregulation of IL-12R was strongly blocked by administration of anti-IL-12 mAb or anti-IFN-␥ mAb before injection of ␣-GalCer (Fig. 4) . Moreover, the IL-12R induction by ␣-GalCer was almost completely abolished in both CD1d Ϫ/Ϫ and V␣14 NKT cell-deficient mice (Fig. 5, A and B). Thus, these results suggested that CD1d-dependent ␣-GalCer-induced IFN-␥ production by NKT cells may be critically important for the upregulation of IL-12R on NKT cells. To provide direct evidence for this hypothesis, we measured the expression of IL-12R on purified NKT cells that were previously activated in the presence of DCs and ␣-GalCer, either in vitro or in vivo. (Fig. 5 D) .
␣-GalCer Synergistically Acts with Exogenously Administered IL-12 in the Activation of Natural Killing Activity and IFN-␥ Production In
Vivo. C57BL/6 mice were injected intravenously with ␣-GalCer, and their splenic natural killing activity against YAC-1 cells was determined 24 h later. As shown in Fig. 6 A, a suboptimal dose of neither ␣-GalCer nor IL-12 was able to activate natural killing activity in vivo. However, combined administration of ␣-GalCer and IL-12 at a suboptimal dose caused a marked augmentation of natural killing.
A similar synergistic effect of ␣-GalCer and IL-12 was demonstrated for the elevation of serum IFN-␥ production. As shown in Fig. 6 B, the administration of ␣-GalCer plus IL-12 resulted in a strong enhancement of serum IFN-␥ levels in C57BL/6 mice compared with mice treated with ␣-GalCer or IL-12 only.
Discussion
The finding that NKT cells recognize ␣-GalCer presented by DCs in a CD1d-dependent manner represents a novel recognition mechanism in the immune system (15) . NKT cells, which can produce both IFN-␥ and IL-4 (16, 17) , play an important role in immunoregulation and have been considered to play a central role as innate effector cells involved in both the protection and the onset of immune diseases (18) . The NKT cell ligand ␣-GalCer has a strong immunopotentiating effect in vivo, and this chemical mediates strong antitumor activity (3) (4) (5) 9) . Therefore, it is important to dissect the mechanism by which ␣-GalCer activates NKT cells.
The previous finding (3) that NKT-deficient mice did not respond to ␣-GalCer strongly suggested that NKT cells may be the primary target cells to ␣-GalCer. However, it still remained unclear whether only NKT cells responded to ␣-GalCer. To answer this question, we used highly purified splenic NK cells, NKT cells, CD4 ϩ T cells, and CD8 ϩ T cells and determined their responsiveness to ␣-GalCer in the presence of DCs. The data illustrated in Fig. 1 clearly demonstrate that NKT cells are the only cells that respond to ␣-GalCer (3). It is surprising that neither classical NK cells nor mainstream CD4 ϩ T cells or CD8 ϩ T cells revealed a significant response to ␣-GalCer even in the presence of DCs. Together with previous findings (3), the present data indicate that ␣-GalCer selectively stimulates NKT cells in the presence of DCs.
Recently, the mechanisms of activation of naive CD4 ϩ T cells through interaction with DCs have been examined (12, (19) (20) (21) (22) . Cell-cell adhesion between CD4 ϩ T cells and DCs through CD40/CD40L and B7.1/CD28 resulted in the activation of both DCs and T cells, which triggered the production of IL-12 by DCs and IFN-␥ by Th1 cells (12, 19, 20, (23) (24) (25) . Such conditioned DCs were able to prime cytotoxic T cells (22, 26, 27) . This recognition system has resemblance to that discussed here. As shown in Fig. 2 , IL-12 production by DCs appears to be essential for NKT cell activation by ␣-GalCer, because neutralization of endogenously produced IL-12 by anti-IL-12 mAb caused a strong inhibition of IFN-␥ production by NKT cells. The important role of CD40/CD40L for the production of IFN-␥ in the cocultures of DCs and NKT cells with ␣-GalCer is also apparent from these experiments (Fig. 2  B) . As demonstrated in Fig. 2 C, DCs produce IL-12 only when they are cultured with ␣-GalCer in the presence of NKT cells, indicating that direct contact between ␣-GalCer-bound DCs and NKT cells may be essential for IL-12 production by DCs. This interaction may be required for the production of IFN-␥ by IL-12-activated NKT cells, because mAbs directed against CD40/CD40L greatly inhibited IFN-␥ production by NKT cells (Fig. 2) . These findings indicate that the interaction of NKT cells with DCs may be very similar to the interaction of helper T cells with DCs (22, 26, 27) . Since the interactions between DCs and NKT cells occur very quickly after administration of ␣-GalCer, NKT cells may be able to condition DCs very early in an immune response, and affect subsequent adaptive responses.
In this paper, we also demonstrate that ␣-GalCer upregulates IL-12R expression in vivo (Fig. 3) . IL-12R upregulation is blocked by mAbs against IL-12 or IFN-␥ and is absent in CD1d Ϫ/Ϫ and NKT-deficient mice (Figs. 4 and  5) . Moreover, activation of NKT cells in vitro and in vivo results in a strong induction of IL-12R␤1 and IL-12R␤2 on these cells (Fig. 5, C and D) . Therefore, we speculate that the following series of events is induced upon culture of ␣-GalCer with DCs and NKT cells: suboptimal ␣-GalCer and exogenously administered IL-12 indicates that expression of IL-12R␤1 and ␤2, detected by quantitative RT-PCR, is functionally upregulated in vivo. Moreover, since this synergistic effect of ␣-GalCer and IL-12 was not demonstrated in NKT-deficient mice, we conclude that in wild-type mice coadministration of ␣-GalCer and IL-12 leads to upregulation of IL-12R on CD1-dependent NKT cells.
Both ␣-GalCer and IL-12 have been demonstrated to exhibit potent antitumor activity in vivo. IL-12 has multiple effects on the immune system that are beneficial for the induction of antitumor immunity in vivo (28) (29) (30) . However, the unexpected severe side effects of IL-12 have made it difficult to use this cytokine in clinical trials (31) . We demonstrated that ␣-GalCer synergistically acts with small doses of IL-12 in vivo to activate NKT cells and to induce IFN-␥ production (Fig. 6 ). These findings suggest that coadministration of ␣-GalCer with IL-12 could be used as a new approach for tumor immunotherapy.
Recent studies have demonstrated that Th1 immunity regulated by IL-12 and IFN-␥ plays a critical role in the induction of protective immunity against tumors and infectious agents (32, 33) . Although NKT cells are involved in both Th1 and Th2 immunity through IFN-␥ or IL-4 production, the immunomodulating protocol using ␣-GalCer and IL-12 preferentially induces NKT cells that produce large amounts of IFN-␥ (34) . These NKT cells may facilitate the development of Th1-dominant cellular immunity essential for the induction of protective immunity against tumors and some infectious agents. Recently, it was demonstrated that ␣-GalCer can stimulate human NKT cells in a CD1d-dependent manner (35, 36) , indicating that our proposed immunotherapy protocol using ␣-GalCer and IL-12 will be useful for the application to human immune diseases, including cancer.
